Literature DB >> 15452120

The C-terminal tails of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas receptors have opposing functions in Fas-associated death domain (FADD) recruitment and can regulate agonist-specific mechanisms of receptor activation.

Lance R Thomas1, Ronald L Johnson, John C Reed, Andrew Thorburn.   

Abstract

Members of the tumor necrosis factor (TNF) superfamily of receptors such as Fas/CD95 and the TNF-related apoptosis-inducing ligand (TRAIL) receptors DR4 and DR5 induce apoptosis by recruiting adaptor molecules and caspases. The central adaptor molecule for these receptors is a death domain-containing protein, FADD, which binds to the activated receptor via death domain-death domain interactions. Here, we show that in addition to the death domain, the C-terminal tails of DR4 and DR5 positively regulate FADD binding, caspase activation and apoptosis. In contrast, the corresponding region in the Fas receptor has the opposite effect and inhibits binding to the receptor death domain. Replacement of wild-type or mutant DR5 molecules into DR5-deficient BJAB cells indicates that some agonistic antibodies display an absolute requirement for the C-terminal tail for FADD binding and signaling while other antibodies can function in the absence of this mechanism. These data demonstrate that regions outside the death domains of DR4 and DR5 have opposite effects to that of Fas in regulating FADD recruitment and show that different death receptor agonists can use distinct molecular mechanisms to activate signaling from the same receptor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15452120     DOI: 10.1074/jbc.M409578200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

Review 1.  Apoptosis and autophagy: regulatory connections between two supposedly different processes.

Authors:  Andrew Thorburn
Journal:  Apoptosis       Date:  2008-01       Impact factor: 4.677

2.  Selective targeting of death receptor 5 circumvents resistance of MG-63 osteosarcoma cells to TRAIL-induced apoptosis.

Authors:  Rachel M Locklin; Ermanno Federici; Belen Espina; Philippa A Hulley; R Graham G Russell; Claire M Edwards
Journal:  Mol Cancer Ther       Date:  2007-12-07       Impact factor: 6.261

Review 3.  Following the TRAIL to apoptosis.

Authors:  Bharti R Chaudhari; Richard F Murphy; Devendra K Agrawal
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

4.  Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor.

Authors:  Almer M van der Sloot; Vicente Tur; Eva Szegezdi; Margaret M Mullally; Robbert H Cool; Afshin Samali; Luis Serrano; Wim J Quax
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-26       Impact factor: 11.205

Review 5.  Regulation of cell survival and death during Flavivirus infections.

Authors:  Sounak Ghosh Roy; Beata Sadigh; Emmanuel Datan; Richard A Lockshin; Zahra Zakeri
Journal:  World J Biol Chem       Date:  2014-05-26

6.  Inhibition of IGF-1R-dependent PI3K activation sensitizes colon cancer cells specifically to DR5-mediated apoptosis but not to rhTRAIL.

Authors:  Bodvael Pennarun; Jan H Kleibeuker; Tjitske Oenema; Janet H Stegehuis; Elisabeth G E de Vries; Steven de Jong
Journal:  Cell Oncol (Dordr)       Date:  2011-04-30       Impact factor: 6.730

7.  Selective inactivation of a Fas-associated death domain protein (FADD)-dependent apoptosis and autophagy pathway in immortal epithelial cells.

Authors:  Jacqueline Thorburn; Franklin Moore; Anuradha Rao; Wendy W Barclay; Lance R Thomas; Ken W Grant; Scott D Cramer; Andrew Thorburn
Journal:  Mol Biol Cell       Date:  2005-01-05       Impact factor: 4.138

8.  Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces death receptor 5 networks that are highly organized.

Authors:  Christopher C Valley; Andrew K Lewis; Deepti J Mudaliar; Jason D Perlmutter; Anthony R Braun; Christine B Karim; David D Thomas; Jonathan R Brody; Jonathan N Sachs
Journal:  J Biol Chem       Date:  2012-04-10       Impact factor: 5.157

9.  Membrane-bound Fas ligand requires RIP1 for efficient activation of caspase-8 within the death-inducing signaling complex.

Authors:  Michael J Morgan; You-Sun Kim; Zheng-gang Liu
Journal:  J Immunol       Date:  2009-07-29       Impact factor: 5.422

10.  Structural basis of LaDR5, a novel agonistic anti-death receptor 5 (DR5) monoclonal antibody, to inhibit DR5/TRAIL complex formation.

Authors:  Chunxia Qiao; Meiyun Hu; Leiming Guo; Ming Lv; Zhou Lin; Jing Geng; Xiaoling Lang; Xinying Li; Yan Li; Yuanfang Ma; Jiannan Feng; Beifen Shen
Journal:  BMC Immunol       Date:  2012-07-12       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.